What does Arrowhead Pharmaceuticals, Inc. do?
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a…
What is Arrowhead Pharmaceuticals, Inc.'s P/E and P/B ratio?
Arrowhead Pharmaceuticals, Inc. has a P/E ratio of -25.6 and a P/B ratio of 17.71.
What is Arrowhead Pharmaceuticals, Inc.'s debt-to-equity ratio?
Arrowhead Pharmaceuticals, Inc. has a debt-to-equity ratio of 2.96.
How much does Arrowhead Pharmaceuticals, Inc. owe compared with what it owns?
Arrowhead Pharmaceuticals, Inc. owes $0.78 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Arrowhead Pharmaceuticals, Inc.'s Positivity rank?
Arrowhead Pharmaceuticals, Inc. is ranked #6,102 of 6,774 companies globally and #3,457 of 4,000 in United States on PositoAI, with a Positivity Score of 9,251.
Does Arrowhead Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Arrowhead Pharmaceuticals, Inc..
Where can I read the latest news about Arrowhead Pharmaceuticals, Inc.?
Recent headlines about Arrowhead Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Arrowhead Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Arrowhead Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.